MaxLinear, Inc. (MXL) financials
NASDAQ · Technology · Semiconductors · 1,115 employees · CEO Kishore Seendripu
- Price
- $67.47 -5.78%
- Market cap
- $6.12B
- Enterprise value
- $6.22B
- Last report
- Q3 '26 filed 2026-10-22
- Next report
- 2027-02-04 EPS est. $0.79
Valuation & key figures
- Market cap
- $6.12B EV $6.22B
- Revenue
- $661M Trailing 12 months
- Revenue growth
- +66% FY2026 consensus
- Profit margin
- -4.4% Net income / revenue, TTM
- P/E
- -192.8× Forward 34.1× (FY2026)
- P/S
- 9.3× Price / sales, TTM
- EV / EBITDA
- 187.7× TTM
- Free cash flow
- -$20.6M Trailing 12 months
- Net income
- -$29.4M Trailing 12 months
- Revenue estimate
- $777M FY2026 consensus
- Earnings
- 2027-02-04 Revenue est. $250M
- Dividend
- – No dividend
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-10-22): revenue beat by 1.4%, EPS beat by 11.1%Revenue $218M vs $215M expected (+1.4%); EPS $0.62 vs $0.56 (+11.1%).
- Revenue growth accelerating: 72.4% year on yearQ3 '26 revenue $218M, against an average of 50.5% over the four quarters before.
- Operating margin -0.8% (TTM), +28.8 pp on a year agoOperating income grew 95.5% while revenue grew 56.0%.
- Capex 2.0% of revenue (a year ago 2.6%)$13.4M invested in the last 4 quarters (+20.6% on a year earlier). Free cash flow -$20.6M.
- Diluted share count up 12.1% in a year97.7M diluted shares in Q3 '26, 87.2M a year earlier.
- Net debt $105MCash + short-term investments $81.1M, debt incl. leases $186M; a year ago net debt $31.9M.
Last quarter: Q3 '26
Quarter ended 2026-09-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q3 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | $218M | $126M | +72.4% |
| Gross margin | 58.7% | 56.6% | +2.2 pp |
| Operating income | $30.2M | -$30M | +200.7% |
| Operating margin | 13.9% | -23.7% | +37.6 pp |
| Net income | $28.9M | -$45.5M | +163.5% |
| Diluted EPS | $0.30 | -$0.52 | +157.7% |
| Operating cash flow | -$13.6M | $10.1M | -234.2% |
| Capex | $5.94M | $5.73M | +3.7% |
| Free cash flow | -$19.5M | $4.4M | -544.4% |
| R&D | $60.6M | $54.3M | +11.8% |
| Stock-based compensation | $19.8M | $0 | – |
Reported vs consensus
2026-10-22| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $218M | $215M | +1.4% |
| EPS (as estimated) | $0.62 | $0.56 | +11.1% |
From the report of 2026-10-22 for Q3 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyRevenue by business line
stacked, quarterly| Segment | Q3 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| Infrastructure | $125M | +209.6% | 57.3% | $319M | +149.3% | |
| Broadband | $53.3M | -8.4% | 24.5% | $200M | +13.2% | |
| Industrial And multi-market | $15.1M | +69.3% | 6.9% | – | – | |
| Connectivity | $24.7M | +30.3% | 11.3% | $85.3M | +6.6% |
Revenue by region
share of total| Segment | Q3 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| Asia | $84.8M | +0.6% | 76.5% | $373M | – | |
| Rest of World | $20.8M | +377.0% | 18.8% | $53.8M | – | |
| United States | $5.2M | +3,482.8% | 4.7% | $15.9M | – |
Margins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- -$7.25M
- Capex
- -$13.4M
- Buybacks
- -$23.7M
- Dividends
- $0
- Acquisitions
- $0
- Net debt issued
- $42M
- Stock-based compensation
- $86.9M
- Free cash flow
- -$20.6M
- Returned to shareholders / FCF
- -115.0%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | -192.8× | 79.1× 2 of 5 years | 21.2× – 137.1× |
| EV / EBITDA | 187.7× | 83.1× 3 of 5 years | 10.2× – 198.2× |
| EV / Sales | 9.4× | 4.0× | 2.3× – 6.7× |
| Price / FCF | -296.8× | 108.1× 4 of 5 years | 7.6× – 215.0× |
| Price / Book | 11.5× | 5.0× | 2.8× – 11.7× |
| FCF yield | -0.3% | 2.5% | -3.8% – 13.1% |
| Return on invested capital | -0.7% | -4.7% | -24.3% – 15.5% |
| Return on equity | -6.1% | -12.3% | -47.5% – 18.5% |
Analysts
Consensus target $100.43 (+48.9%)
range $70.00 – $125.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $777M | +66.1% | $1.98 | +225.1% | 34.1× | 6 |
| FY2027 | $1.38B | +78.3% | $4.66 | +135.9% | 14.5× | 6 |
| FY2028 | $1.83B | +32.3% | $5.72 | +22.8% | 11.8× | 6 |
| FY2029 | $1.7B | -7.3% | $5.03 | -12.1% | 13.4× | 3 |
| FY2030 | $1.56B | -8.4% | $5.25 | +4.4% | 12.9× | 2 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Every reported line
All 294 figures MaxLinear, Inc. tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).
| Line (SEC label) | Latest quarter | Year ago | y/y | Latest FY | Prior FY | y/y |
|---|---|---|---|---|---|---|
| Accounts Payable, Current | $36.5M | $31.4M | +16.1% | $37.9M | $31.4M | +20.8% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $73.4M | $52.9M | +38.6% | $46.1M | $85.5M | -46.0% |
| Accrued Bonuses | $27.5M | $26.7M | +3.0% | $32.4M | $4.9M | +561.2% |
| Accrued Income Taxes, Current | $444K | $613K | -27.6% | $511K | $745K | -31.4% |
| Accrued Liabilities, Current | $64.5M | $76.8M | -16.1% | $72.4M | $87.4M | -17.2% |
| Accrued Professional Fees, Current | $2.47M | $10.4M | -76.3% | $6.88M | $7.1M | -3.1% |
| Accrued Royalties, Current | $549K2026-03-31 | $375K | +46.4% | $658K | $438K | +50.2% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $171M | $154M | +10.9% | $158M | $136M | +15.8% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $641K | $160K | +300.6% | $1.03M | -$6.82M | +115.1% |
| Additional Paid in Capital, Common Stock | $1.05B | $950M | +10.2% | $951M | $887M | +7.3% |
| Amortization of Debt Issuance Costs and Discounts | $200K | $200K | 0.0% | $600K | $600K | 0.0% |
| Amortization of Intangible Assets | $3.44M | $3.31M | +4.1% | $13.3M | $23.2M | -42.5% |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 97K | 4.5M | -97.8% | 6.1M | 6.8M | -10.3% |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $19.8M | $21.4M | -7.6% | $77.2M | $66M | +17.0% |
| Asset Impairment Charges | $0 | $0 | – | $0 | $0 | – |
| Assets | $916M | $808M | +13.4% | $796M | $865M | -7.9% |
| Assets, Current | $391M | $284M | +37.7% | $249M | $323M | -23.1% |
| Business Combination, Contingent Consideration, Liability | $2.6M | $2.6M | 0.0% | $2.6M | $2.6M | 0.0% |
| Business Combination, Contingent Consideration, Liability, Current | $2.6M | $2.6M | 0.0% | $2.6M | $2.6M | 0.0% |
| Cash and Cash Equivalents, at Carrying Value | $81.1M | $112M | -27.5% | $72.8M | $119M | -38.6% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $110M | $113M | -3.0% | $101M | $120M | -15.2% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $16.1M | $3.01M | +435.9% | -$18.2M | -$68.8M | +73.5% |
| Common Stock, Par or Stated Value Per Share | $0.00 | $0.00 | 0.0% | $0.00 | $0.00 | 0.0% |
| Common Stock, Shares Authorized | 550M | 550M | 0.0% | 550M | 550M | 0.0% |
| Common Stock, Shares, Issued | 91M | 87.4M | +4.2% | 86.5M | 84.6M | +2.2% |
| Common Stock, Shares, Outstanding | 91M | 87.4M | +4.2% | 86.5M | 84.6M | +2.2% |
| Common Stock, Value, Issued | $9K | $9K | 0.0% | $9K | $8K | +12.5% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $28.2M | -$45.6M | +161.8% | -$129M | -$248M | +48.1% |
| Contract with Customer, Liability | $284K | $76K | +273.7% | $4.22M | $114K | +3,603.5% |
| Contract with Customer, Right to Recover Product | $100K | $100K | 0.0% | $100K | $100K | 0.0% |
| Contractual Obligation | $348M | $121M | +187.2% | $210M | $107M | +96.7% |
| Contractual Obligation, to be Paid, after Year Five | $2.79M2025-12-31 | – | – | $2.79M | – | – |
| Contractual Obligation, to be Paid, Remainder of Fiscal Year | $100M | $45.1M | +121.7% | – | – | – |
| Contractual Obligation, to be Paid, Year Five | $647K2025-12-31 | – | – | $647K | – | – |
| Contractual Obligation, to be Paid, Year Four | $647K | $629K | +2.9% | $629K | $0 | – |
| Contractual Obligation, to be Paid, Year One | $211M | $55.3M | +282.4% | $146M | $72M | +103.4% |
| Contractual Obligation, to be Paid, Year Three | $10.9M | $1.11M | +881.8% | $1.11M | $3.67M | -69.8% |
| Contractual Obligation, to be Paid, Year Two | $21.8M | $15.4M | +41.5% | $58M | $30.9M | +87.9% |
| Cost of Revenue | $90M | $54.6M | +64.9% | $202M | $166M | +21.8% |
| Current Federal Tax Expense (Benefit) | – | – | – | $4.82M | $893K | +439.3% |
| Current Foreign Tax Expense (Benefit) | – | – | – | -$436K | $4.74M | -109.2% |
| Current Income Tax Expense (Benefit) | – | – | – | $4.39M | $5.65M | -22.4% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $5K | $16K | -68.8% |
| Debt Instrument, Interest Rate, Effective Percentage | 7.0% | 7.0% | 0.0% | 6.9% | 7.8% | -11.5% |
| Debt Instrument, Unamortized Discount | $226K | – | – | $2.1M2017-05-12 | – | – |
| Debt Issuance Costs, Net | $712K | – | – | – | – | – |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | -$13.7M | -$10.8M | -27.0% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | $4.27M | -$10.9M | +139.3% |
| Deferred Income Tax Assets, Net | $65.4M | $74.8M | -12.5% | $77.3M | $68.7M | +12.5% |
| Deferred Income Tax Expense (Benefit) | -$3.06M | $275K | -1,212.4% | -$8.6M | $833K | -1,132.2% |
| Deferred Income Taxes and Tax Credits | – | – | – | -$8.6M | $826K | -1,140.6% |
| Deferred State and Local Income Tax Expense (Benefit) | – | – | – | -$3.11M | -$3.54M | +12.0% |
| Deferred Tax Assets, Goodwill and Intangible Assets | $7.74M2025-12-31 | $9.7M | -20.2% | $7.74M | $9.7M | -20.2% |
| Deferred Tax Assets, Gross | $184M2025-12-31 | $171M | +7.4% | $184M | $171M | +7.4% |
| Deferred Tax Assets, Net | $77.1M2025-12-31 | $68.5M | +12.5% | $77.1M | $68.5M | +12.5% |
| Deferred Tax Assets, Net of Valuation Allowance | $79.4M2025-12-31 | $71.1M | +11.6% | $79.4M | $71.1M | +11.6% |
| Deferred Tax Assets, Operating Loss Carryforwards | $53.7M2025-12-31 | $39.3M | +36.8% | $53.7M | $39.3M | +36.8% |
| Deferred Tax Assets, Tax Credit Carryforwards, Foreign | $527K2025-12-31 | $1.58M | -66.6% | $527K | $1.58M | -66.6% |
| Deferred Tax Assets, Tax Credit Carryforwards, Research | $86.1M2025-12-31 | $85.7M | +0.5% | $86.1M | $85.7M | +0.5% |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation | $6.9M2025-12-31 | $2.99M | +130.6% | $6.9M | $2.99M | +130.6% |
Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
Data as of 2026-11-02